Carbapenem-resistant Escherichia coli from shrimp and salmon available for purchase by consumers in Canada: a risk profile using the Codex framework
| Autor: | Daleen Loest, F. Carl Uhland, Kaitlin M. Young, Xian-Zhi Li, Michael R. Mulvey, Richard Reid-Smith, Lauren M. Sherk, Carolee A. Carson |
|---|---|
| Rok vydání: | 2022 |
| Předmět: | |
| Zdroj: | Epidemiology and Infection. 150 |
| ISSN: | 1469-4409 0950-2688 |
| DOI: | 10.1017/s0950268822001030 |
| Popis: | Resistance to carbapenems in human pathogens is a growing clinical and public health concern. The carbapenems are in an antimicrobial class considered last-resort, they are used to treat human infections caused by multidrug-resistant Enterobacterales, and they are classified by the World Health Organization as ‘High Priority Critically Important Antimicrobials’. The presence of carbapenem-resistant Enterobacterales (CREs) of animal-origin is of concern because targeted studies of Canadian retail seafood revealed the presence of carbapenem resistance in a small number of Enterobacterales isolates. To further investigate this issue, a risk profile was developed examining shrimp and salmon, the two most important seafood commodities consumed by Canadians and Escherichia coli, a member of the Enterobacterales order. Carbapenem-resistant E. coli (CREc) isolates have been identified in shrimp and other seafood products. Although carbapenem use in aquaculture has not been reported, several classes of antimicrobials are utilised globally and co-selection of antimicrobial-resistant microorganisms in an aquaculture setting is also of concern. CREs have been identified in retail seafood purchased in Canada and are currently thought to be uncommon. However, data concerning CRE or CREc occurrence and distribution in seafood are limited, and argue for implementation of ongoing or periodic surveillance. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|